Healthcare Tech & Data: Frazier Healthcare Partners has agreed to buy MatrixCare from Resmed, expanding its reach in post-acute EHR software for skilled nursing, senior living, home health and hospice. Regulatory & Supply Chain: The FDA picked seven firms for its PreCheck Pilot to give earlier feedback on new U.S. manufacturing sites, aiming to reduce uncertainty and strengthen drug supply. Cell & Gene Therapy: A new “in vivo” CAR T approach is being explored for autoimmune disease, while other CAR T designs target tumor “stump” regions to avoid antigen shedding. Oncology Imaging: A second PSMA PET after an initial negative scan found disease in about 56% of recurrent prostate cancer patients, driving management changes for nearly half. Women’s Health: A Lancet Haematology commission calls for better, earlier care for women and girls with blood disorders, including heavy bleeding and clotting complications. Public Health: A UK report urges a non-stigmatising, UK-wide alcohol-and-pregnancy prevention push for FASD, citing a large national cost. Infection Risk: Doctors warn floodwater can spread leptospirosis, especially when it contacts cuts or breaks in skin. Primary Care Capacity: England’s GP workforce is shrinking in full-time equivalents, with long waits for appointments adding pressure. Policy & Access: EU leaders are pushing for age limits on social media for minors, with phased access and parent supervision. Clinical Safety: Coverage highlights pulmonary embolism risk after surgery and the prevention steps hospitals use.